Eventide Asset Management - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 152 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q1 2023$21,558,900
-67.1%
1,390,000
-62.4%
0.40%
-69.4%
Q4 2022$65,563,530
+118.7%
3,693,720
-31.2%
1.29%
+119.2%
Q3 2022$29,979,000
+43.1%
5,372,5120.0%0.59%
+31.7%
Q2 2022$20,953,000
-29.2%
5,372,5120.0%0.45%
-3.4%
Q1 2022$29,603,000
-29.8%
5,372,512
+8.5%
0.46%
-13.9%
Q4 2021$42,174,000
-2.0%
4,950,0000.0%0.54%
-4.9%
Q3 2021$43,016,000
+20.7%
4,950,000
+46.8%
0.57%
+18.4%
Q2 2021$35,631,000
-10.2%
3,370,994
+36.3%
0.48%
-18.5%
Q1 2021$39,667,000
-7.9%
2,473,000
+165.3%
0.59%
-10.9%
Q4 2020$43,049,000
+31.3%
932,0000.0%0.66%
+2.8%
Q3 2020$32,797,000
+115.2%
932,000
+48.9%
0.64%
+94.0%
Q2 2020$15,242,000625,9500.33%
Other shareholders
IMMUNOVANT INC shareholders Q2 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,717,182$139,213,0003.92%
Ghost Tree Capital, LLC 525,000$12,784,0003.37%
Logos Global Management LP 625,000$15,219,0003.04%
ACUTA CAPITAL PARTNERS, LLC 350,000$8,523,0002.46%
BVF INC/IL 1,088,479$26,504,0001.63%
Vivo Capital, LLC 800,000$19,480,0001.40%
Camber Capital Management LP 800,000$19,480,0001.12%
Sio Capital Management, LLC 152,450$3,712,0001.08%
Prosight Management, LP 95,500$2,325,0001.00%
Parkman Healthcare Partners LLC 125,125$3,047,0000.86%
View complete list of IMMUNOVANT INC shareholders